Dr. Richard Frank, MD
Claim this profileNorwalk Hospital
Studies Pancreatic Cancer
Studies Breast Cancer
18 reported clinical trials
36 drugs studied
About Richard Frank, MD
Education:
- Obtained an MD (Doctor of Medicine) from the University of Connecticut School of Medicine in 1987.
- Completed a Residency in Internal Medicine at Norwalk Hospital in 1990.
Experience:
- Affiliated with Norwalk Hospital, where he has likely continued his practice in Internal Medicine.
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
2Breast Cancer
Stage IV
HER2 positive
Stage III
Affiliated Hospitals
Clinical Trials Richard Frank, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Pembrolizumab + Olaparib
for Pancreatic Cancer
This phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline BRCA1 or BRCA2 mutations that has spread to other places in the body (metastatic). BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. These proteins help repair damaged deoxyribonucleic acid (DNA) and, therefore, play a role in ensuring the stability of each cell's genetic material. When either of these genes is mutated, or altered, such that its protein product is not made or does not function correctly, DNA damage may not be repaired properly. As a result, cells are more likely to develop additional genetic alterations that can lead to some types of cancer, including pancreatic cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Olaparib is an inhibitor of PARP, a protein that helps repair damaged DNA. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of pembrolizumab to the usual treatment of olaparib may help to shrink tumors in patients with metastatic pancreatic cancer with BRCA1 or BRCA2 mutations.
Recruiting1 award Phase 237 criteria
More about Richard Frank, MD
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Richard Frank, MD has experience with
- Pembrolizumab
- Atezolizumab
- Paclitaxel
- Trastuzumab
- Pertuzumab
- Carboplatin
Breakdown of trials Richard Frank, MD has run
Pancreatic Cancer
Breast Cancer
Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard Frank, MD specialize in?
Richard Frank, MD focuses on Pancreatic Cancer and Breast Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Richard Frank, MD currently recruiting for clinical trials?
Yes, Richard Frank, MD is currently recruiting for 9 clinical trials in Norwalk Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Richard Frank, MD has studied deeply?
Yes, Richard Frank, MD has studied treatments such as Pembrolizumab, Atezolizumab, Paclitaxel.
What is the best way to schedule an appointment with Richard Frank, MD?
Apply for one of the trials that Richard Frank, MD is conducting.
What is the office address of Richard Frank, MD?
The office of Richard Frank, MD is located at: Norwalk Hospital, Norwalk, Connecticut 06856 United States. This is the address for their practice at the Norwalk Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.